Literature DB >> 12794218

Is increased surveillance for asymptomatic syphilis in an HIV outpatient department worthwhile?

A Winston1, D Hawkins, S Mandalia, F Boag, B Azadian, D Asboe.   

Abstract

OBJECTIVES: Syphilis outbreaks have recently been reported in the United Kingdom, some of which have included cohorts of HIV positive individuals. As a result we commenced 3 monthly screening of syphilis serology (STS) for HIV positive patients having routine follow up blood tests. We assessed if there was an increased number of individuals being screened and also whether the screening programme was diagnosing early cases of syphilis.
METHODS: Data from a 1 year period following introduction of screening (May 2001) were analysed and compared with data from the same period last year. The case notes of patients with a positive VDRL were reviewed to establish, firstly, whether these represented new diagnoses and, secondly, whether patients were asymptomatic at the time of screening.
RESULTS: 2670 patients had at least one CD4 count measured in the period (surrogate for patients having routine bloods). Of these, 2266 patients had STS performed (85%). 38 patients had a positive VDRL. Of these, 20 were confirmed as having early syphilis which was asymptomatic at the time of screening. Six asymptomatic cases were also confirmed with newly positive TPPAs and a negative VDRL. These 26 asymptomatic cases represent 29% of all cases of early syphilis diagnosed in our department and 50% of cases in the HIV positive cohort.
CONCLUSION: With intensive surveillance significant numbers of cases of asymptomatic early syphilis are being identified in a group of HIV individuals under routine follow up, at an earlier stage than would otherwise have been the case. This presents an opportunity to intervene not only to prevent clinical illness but also to institute infection control measures.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12794218      PMCID: PMC1744658          DOI: 10.1136/sti.79.3.257

Source DB:  PubMed          Journal:  Sex Transm Infect        ISSN: 1368-4973            Impact factor:   3.519


  7 in total

1.  Lessons from the syphilis outbreak in homosexual men in east London.

Authors:  M Hourihan; H Wheeler; R Houghton; B T Goh
Journal:  Sex Transm Infect       Date:  2004-12       Impact factor: 3.519

2.  New syphilis cases and concurrent STI screening in a southeastern U.S. HIV clinic: a call to action.

Authors:  Cynthia W Baffi; Inmaculada Aban; James H Willig; Mayank Agrawal; Michael J Mugavero; Laura H Bachmann
Journal:  AIDS Patient Care STDS       Date:  2010-01       Impact factor: 5.078

3.  Increasing detection of asymptomatic syphilis in HIV patients.

Authors:  C E Cohen; A Winston; D Asboe; F Boag; S Mandalia; B Azadian; D A Hawkins
Journal:  Sex Transm Infect       Date:  2005-06       Impact factor: 3.519

4.  Incidence of syphilis seroconversion among HIV-infected persons in Asia: results from the TREAT Asia HIV Observational Database.

Authors:  Jin Young Ahn; David Boettiger; Sasisopin Kiertiburanakul; Tuti Parwati Merati; Bui Vu Huy; Wing Wai Wong; Rossana Ditangco; Man Po Lee; Shinichi Oka; Nicolas Durier; Jun Yong Choi
Journal:  J Int AIDS Soc       Date:  2016-10-21       Impact factor: 5.396

5.  Increasing incidence of syphilis among patients engaged in HIV care in Alberta, Canada: a retrospective clinic-based cohort study.

Authors:  Raynell Lang; Ron Read; Hartmut B Krentz; Soheil Ramazani; Mingkai Peng; Jennifer Gratrix; M John Gill
Journal:  BMC Infect Dis       Date:  2018-03-13       Impact factor: 3.090

6.  Correlates of prevalent syphilis infection among men who have sex with men (MSM) living with HIV attending the HIV clinic in Trinidad.

Authors:  R Jeffrey Edwards; Abigail Mohammed; Leon-Omari Lavia; Jonathan Edwards; Shiva Verma; Saketh Reddy; Gregory Boyce
Journal:  PLoS One       Date:  2022-03-31       Impact factor: 3.240

7.  Managing Syphilis in the HIV-infected Patient.

Authors:  Christopher S. Hall; Jeffrey D. Klausner; Gail A. Bolan
Journal:  Curr Infect Dis Rep       Date:  2004-02       Impact factor: 3.663

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.